Canterbury dairy processor Synlait's Chinese infant formula business is being disrupted by regulatory changes in the world's second biggest economy and the company says it may miss its baby milk sales target for this financial year.
But managing director John Penno says a major overhaul of China's booming infant formula market - which is estimated to be worth more than US$12 billion ($14.5 billion) annually - is expected to benefit Synlait in the long-term.
The regulatory changes introduced by the Chinese Government last year aim to rebuild an industry that was decimated by the 2008 melamine crisis, when six babies died and hundreds of thousands more became sick after consuming dairy products tainted with the industrial chemical.
Beijing wants to consolidate the market through the creation of "national champions" that can compete against the foreign infant formula manufacturers whose sales spiked in China after the melamine scandal, which left many parents distrustful of domestically manufactured products.